Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Composite Measurements of Extracellular Matrix Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia

NCT06154954 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT06154954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06154954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Composite Measurements of Extracellular Matrix Protein1, Testis-Expressed Gene 101, and Lectin Galactoside-binding Protein in Predicting Surgical Sperm Retrieval in Men With Non-Obstructive Azoospermia
Lead sponsor
Cairo University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2022
Completion date
March 30, 2024
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-obstructive azoospermia